Stella Kourembanas

Stella Kourembanas, MD

Associate in Medicine, Chief of the Division of Newborn Medicine and Academic Program in Neonatology at Harvard University

Clement A. Smith Professor of Pediatrics

  • Contact: 617-919-2355

  • Fax: 617-730-0260

Medical Services

Specialties

  • Newborn Medicine

Departments

  • Medicine
  • Newborn Medicine
To schedule an appointment: Call 617-919-2355

Experience and Education

Education

Medical School

New York University School of Medicine, 1982

New York, NY

Fellowship

Joint Program in Neonatology - Harvard Medical School, 1984-1987

Boston, MA

Internship

Massachusetts General Hospital, 1982-1983

Boston, MA

Residency

Massachusetts General Hospital, 1983-1984

Boston, MA

Certifications

  • Pediatrics, Neonatal-Perinatal Medicine

Publications

Publications powered by Harvard Catalyst Profiles
  1. Mitsialis SA, Kourembanas S. Stem cell-based therapies for the newborn lung and brain: Possibilities and challenges. Semin Perinatol. 2016 Apr; 40(3):138-51.
  2. Cruz FF, Borg ZD, Goodwin M, Sokocevic D, Wagner DE, Coffey A, Antunes M, Robinson KL, Mitsialis SA, Kourembanas S, Thane K, Hoffman AM, McKenna DH, Rocco PR, Weiss DJ. Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. Stem Cells Transl Med. 2015 Nov; 4(11):1302-16.
  3. Vitali SH, Hansmann G, Rose C, Fernandez-Gonzalez A, Scheid A, Mitsialis SA, Kourembanas S. The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up. Pulm Circ. 2014 Dec; 4(4):619-29.
  4. Kourembanas S. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol. 2015; 77:13-27.
  5. Hale A, Lee C, Annis S, Min PK, Pande R, Creager MA, Julian CG, Moore LG, Mitsialis SA, Hwang SJ, Kourembanas S, Chan SY. An Argonaute 2 switch regulates circulating miR-210 to coordinate hypoxic adaptation across cells. Biochim Biophys Acta. 2014 Nov; 1843(11):2528-42.
  6. Kourembanas S. Expanding the pool of stem cell therapy for lung growth and repair. Circulation. 2014 May 27; 129(21):2091-3.
  7. Kourembanas S. Stem cell-based therapy for newborn lung and brain injury: feasible, safe, and the next therapeutic breakthrough? J Pediatr. 2014 May; 164(5):954-6.
  8. Sdrimas K, Kourembanas S. MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal. 2014 Nov 1; 21(13):1905-15.
  9. Xiao Y, Christou H, Liu L, Visner G, Mitsialis SA, Kourembanas S, Liu H. Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med. 2013 Aug 15; 188(4):482-91.
  10. Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thébaud B, Trapnell BC, Weiss DJ, Yuan JX, Blaisdell CJ. Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med. 2013 Aug 1; 188(3):370-5.
  11. Show all
  12. Hamvas A, Deterding R, Balch WE, Schwartz DA, Albertine KH, Whitsett JA, Cardoso WV, Kotton DN, Kourembanas S, Hagood JS. Diffuse lung disease in children: summary of a scientific conference. Pediatr Pulmonol. 2014 Apr; 49(4):400-9.
  13. Lee C, Mitsialis SA, Aslam M, Vitali SH, Vergadi E, Konstantinou G, Sdrimas K, Fernandez-Gonzalez A, Kourembanas S. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation. 2012 Nov 27; 126(22):2601-11.
  14. Angelidou A, Asadi S, Alysandratos KD, Karagkouni A, Kourembanas S, Theoharides TC. Perinatal stress, brain inflammation and risk of autism-review and proposal. BMC Pediatr. 2012; 12:89.
  15. Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali SH, Martin T, Mitsialis SA, Kourembanas S. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ. 2012 Apr-Jun; 2(2):170-81.
  16. Anversa P, Perrella MA, Kourembanas S, Choi AM, Loscalzo J. Regenerative pulmonary medicine: potential and promise, pitfalls and challenges. Eur J Clin Invest. 2012 Aug; 42(8):900-13.
  17. Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex Mitsialis S, Kourembanas S, Kim CF. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012 May 1; 302(9):L829-37.
  18. Fernandez-Gonzalez A, Alex Mitsialis S, Liu X, Kourembanas S. Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012 Apr 15; 302(8):L775-84.
  19. Christou H, Reslan OM, Mam V, Tanbe AF, Vitali SH, Touma M, Arons E, Mitsialis SA, Kourembanas S, Khalil RA. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2012 May 1; 302(9):L875-90.
  20. Vergadi E, Chang MS, Lee C, Liang OD, Liu X, Fernandez-Gonzalez A, Mitsialis SA, Kourembanas S. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation. 2011 May 10; 123(18):1986-95.
  21. Liang OD, Mitsialis SA, Chang MS, Vergadi E, Lee C, Aslam M, Fernandez-Gonzalez A, Liu X, Baveja R, Kourembanas S. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells. 2011 Jan; 29(1):99-107.
  22. Kourembanas S, Steinhorn R. In-house neonatology: what are we waiting for? Am J Respir Crit Care Med. 2010 Sep 15; 182(6):728-9.
  23. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S. Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med. 2009 Dec 1; 180(11):1122-30.
  24. Vitali SH, Mitsialis SA, Liang OD, Liu X, Fernandez-Gonzalez A, Christou H, Wu X, McGowan FX, Kourembanas S. Divergent cardiopulmonary actions of heme oxygenase enzymatic products in chronic hypoxia. PLoS One. 2009; 4(6):e5978.
  25. Fernandez-Gonzalez A, Kourembanas S, Wyatt TA, Mitsialis SA. Mutation of murine adenylate kinase 7 underlies a primary ciliary dyskinesia phenotype. Am J Respir Cell Mol Biol. 2009 Mar; 40(3):305-13.
  26. Fredenburgh LE, Liang OD, Macias AA, Polte TR, Liu X, Riascos DF, Chung SW, Schissel SL, Ingber DE, Mitsialis SA, Kourembanas S, Perrella MA. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. Circulation. 2008 Apr 22; 117(16):2114-22.
  27. Fredenburgh L, Liang O, Macias A, Polte T, Riascos D, Chung SW, Schissel S, Ingber D, Mitsialis SA, Kourembanas S, Perella M. Absence of COX-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells. J Clin Invest. Submitted. 2007.
  28. Wu X, Chang, MS, Mitsialis, SA, Kourembanas, S. Hypoxia regulates bone morphogenetic protein signaling in vascular smooth muscle cells through CtBP-1. Circ. Res. 2006; 99:240-247.
  29. Wu X, Chang MS, Mitsialis SA, Kourembanas S. Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1. Circ Res. 2006 Aug 4; 99(3):240-7.
  30. Fernandez-Gonzalez A, Naghshineh S, Mitsialis SA, Kourembanas S. Heme oxygenase-1 (HO-1) overexpression prevents fibrosis and iron deposition in developmental lung injury. American Thoracic Society International Conference Proceedings. 2006; 3:A254.
  31. Liang OD, Mitsialis SA, Kourembanas S. . Bone marrow derived mesenchymal stem cells expressing human heme oxygenase-1 (HO-1) reverse hypoxic pulmonary hypertension in HO-1 null mice. American Thoracic Society International Conference Proceedings. 2006; 3:A25.
  32. Fredenburgh LE, Liang OD, Macias AA, Mitsialis SA, Kourembanas S , Perrella MA. Exacerbation of hypoxia-induced pulmonary hypertension and vascular remodeling in COX-2 deficient mice. American Thoracic Society International Conference Proceedings. 2006; 3:A278.
  33. Vitali SH, Mitsialis SA, Christou H, Fernandez-Gonzalez A, Liu X, Kourembanas S. Mechanisms of heme oxygenase-1-mediated cardiac and pulmonary vascular protection in chronic hypoxia: roles of carbon monoxide and bilirubin. Chest. 2005 Dec; 128(6 Suppl):578S-579S.
  34. Danhaive O, Margossian R, Geva T, Kourembanas S. Pulmonary hypertension and right ventricular dysfunction in growth-restricted, extremely low birth weight neonates. J Perinatol. 2005 Jul; 25(7):495-9.
  35. Christou H, Bailey N, Kluger MS, Mitsialis SA, Kourembanas S. Extracellular acidosis induces heme oxygenase-1 expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2005 Jun; 288(6):H2647-52.
  36. Vitali S, Mitsialis SA, Christou H, Kluger M, Liu X, Kourembanas S. . HO-1 mediated cardiac protection in chronic hypoxia: Role of carbon monoxide and bilirubin. 4th International HO Conference, Boston, MA. 2005.
  37. Liang O, Mitsialis SA, Kourembanas S. . Bone-marrow derived mesenchymal stem cells expressing human HO-1 reverse hypoxic pulmonary hypertension in HO-1 null mice. 4th International HO Conference, Boston, MA. 2005.
  38. Fernandez-Gonzalez A, Naghshineh S, Mitsialis SA, Kourembanas S. . Heme Oxygenase-1 overexpression decreases alveolar remodeling and iron deposition in developmental lung injury. 4th International CO Conference, Boston, MA. 2005.
  39. Zampetaki A, Mitsialis SA, Pfeilschifter J, Kourembanas S. Hypoxia induces macrophage inflammatory protein-2 (MIP-2) gene expression in murine macrophages via NF-kappaB: the prominent role of p42/ p44 and PI3 kinase pathways. FASEB J. 2004 Jul; 18(10):1090-2.
  40. Wu X, Kourembanas S . Hypoxia suppresses bone morphogenetic protein mediated Id1 gene activation n human pulmonary artery smooth muscle cells. Am. J. Respir. Crit. Care Med. 2004; A510.
  41. Vitali S, Mitsialis SA, Christou H, Kourembanas S . Mechanisms of HO-1 cytoprotection in hypoxic pulmonary hypertension. Pediatric Research. 2004; 55(4):A2683.
  42. Kourembanas S. Shock. Manual of Neonatal Care(Cloherty JP, Eichenwald E, Stark AR, eds.). 2004; 181-185.
  43. Zampetaki A, Minamino T, Mitsialis SA, Kourembanas S. Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med (Maywood). 2003 May; 228(5):442-6.
  44. Christou H, Mitsialis SA, Kourembanas S. Regulation of heme oxygenase-1 (HO-1) gene expression in vascular smooth muscle cells by extracellular acidosis. Pediatric Research. 2003; 53(4):A3220.
  45. Kourembanas S. Hypoxia and carbon monoxide in the vasculature. Antioxid Redox Signal. 2002 Apr; 4(2):291-9.
  46. Kourembanas S, Minamino T, Christou H, Hsieh C-M, Liu Y, Dhawan V, Atwater L, Abraham NG, Perrella MA, Mitsialis SA. Targeted expression of heme oxygenase-1 and pulmonary responses to hypoxia. Heme Oxygenase in Biology and Medicine. 2002; 193-204.
  47. Brodsky D, Christou H, Bernfield M, Kourembanas S. Response of the developing lung to injury (Haddad GG, Abman S, Chernik V, eds.). Basic Mechanisms of Pediatric Respiratory Disease. 2002; 102-123.
  48. Zampetaki A, Mitsialis SA, Pfeilschifter J, Kourembanas, S. Regulation of macrophage inflammatory protein-2 (MIP-2) gene expression by hypoxia. Am. J. Respir. Crit. Care Med. 2002; 165(8):A546.
  49. Minamino T, Kourembanas S. Mechanisms of telomerase induction during vascular smooth muscle cell proliferation. Circ Res. 2001 Aug 3; 89(3):237-43.
  50. Minamino T, Christou H, Hsieh CM, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8798-803.
  51. Ellington M, O'Reilly D, Allred EN, McCormick MC, Wessel DL, Kourembanas S. Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 2001 Jun; 107(6):1351-6.
  52. Minamino T, Mitsialis SA, Kourembanas S. Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol. 2001 May; 21(10):3336-42.
  53. Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S. Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn. Crit Care Med. 2000 Nov; 28(11):3722-7.
  54. Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res. 2000 Jun 23; 86(12):1224-9.
  55. Christou H, Minamino T, Hsieh C-M, Liu Y, Lynch L, Mitsialis SA, Perrella MA, Kourembanas S. Transgenic mice overexpressing heme oxygenase-1 (HO-1) in the lung are protected from development of hypoxia-induced pulmonary hypertension: Evidence of antiinflammatory effects of HO-1. Pediatric Research. 2000; 47(4):A385.
  56. Kourembanas S, Minamino T, Christou H, Hsieh C-M, Liu Y, Dhawan V, Lynch L, Abraham NG, Perrella MA, Mitsialis SA. Heme oxygenase and pulmonary responses to hypoxia. Acta Haematologica. 2000; 103(1):A247.
  57. Brodsky S, Mitsialis SA, Minamino T, Kourembanas S. Herbimycin A and geldanamycin inhibit the hypoxic induction of the vascular endothelial growth factor (VEGF) gene in pulmonary artery endothelial cells. Pediatric Research. 2000; 47(4):A380.
  58. Christou H, Minamino T, Mitsialis SA, Kourembanas S. Extracellular acidosis induces heme oxygenase-1 (HO-1) gene expression in vascular smooth muscle cells. Pediatric Research. 2000; 47(4):A386.
  59. Yet S-F, Perrella MA, Christou H, Tian R, Ingwall J, Kourembanas S, Lee M-E. The role of heme oxygenase-1 in the regulation of cardiomyocyte death during ischemia/reperfusion. Acta Haematologica. 2000; 103(1):A276.
  60. Maemura K, Hsieh CM, Jain MK, Fukumoto S, Layne MD, Liu Y, Kourembanas S, Yet SF, Perrella MA, Lee ME. Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem. 1999 Oct 29; 274(44):31565-70.
  61. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee ME. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999 Apr; 103(8):R23-9.
  62. Maemura K, Mukesh JK, Hsieh C-M, Fukumoto S, Kourembanas S, Yet S-F, Perrella MA, Lee M-E. Functional analysis of endothelial PAS domain Protein 1: Generation of a dominant negative mutant by deleting C-terminal potent transactivation domain. Circulation. 1999; 100(18):A193.
  63. Christou H, Magnani B, Morse DS, Allred EN, Van Marter LJ, Wessel DL, Kourembanas S. Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn. Pediatrics. 1998 Dec; 102(6):1390-3.
  64. Kourembanas S, Morita T, Christou H, Liu Y, Koike H, Brodsky D, Arthur V, Mitsial SA. Hypoxic responses of vascular cells. Chest. 1998 Jul; 114(1 Suppl):25S-28S.
  65. Liu Y, Christou H, Morita T, Laughner E, Semenza GL, Kourembanas S. Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer. J Biol Chem. 1998 Jun 12; 273(24):15257-62.
  66. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 1998 Jun; 18(6):768-76.
  67. Christou H, Van Marter LJ, Wessel DL, Allred EN, Kane JW, Thompson JE, Stark AR, Kourembanas S. Combination of inhaled nitric oxide with high frequency ventilation reduces the need for extracorporeal membrane oxygenation in infants with persistant pulmonary hypertension of the newborn: Results from a single center trial. Pediatric Research. 1998; 43(4):169A.
  68. Kourembanas S. Shock. Manual of Neonatal Care (Cloherty JP and Stark AR, eds.). 1998; 171-173.
  69. Maemura K, Jain MK, Decarie LA, Liu Y, Kourembanas S, Milstone DS, Lee S-L, Perrella MA, Yet S-F, Lee M-E. Activation of KDR/flk-1 promoter by endothelial PAS domain protein-1: Potential role of endothelial PAS domain protein-1 in endothelial cell differentiation. Circulation. 1998.
  70. Maemura K, Fukumoto S, Jain MK, Kourembanas S, Perrella MA, Yet S-F, Lee M-E. Characterization of functional domains of endothelial PAS domain protein-1 and generation of a dominant negative mutant. Circulation. 1998.
  71. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem. 1997 Dec 26; 272(52):32804-9.
  72. Wessel DL, Adatia I, Van Marter LJ, Thompson JE, Kane JW, Stark AR, Kourembanas S. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 1997 Nov; 100(5):E7.
  73. Hammerman SI, Kourembanas S, Conca TJ, Tucci M, Brauer M, Farber HW. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med. 1997 Jul; 156(1):280-5.
  74. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, Kourembanas S. Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5'-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr. 1997 Apr; 130(4):603-11.
  75. Kourembanas S, Morita T, Liu Y, Christou H. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int. 1997 Feb; 51(2):438-43.
  76. Christou H, Morita T, Koike H, Hsieh, CM, Perrella M, Kourembanas S. Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Pediatric Research. 1997; 41:A238.
  77. Morita T, Kourembanas S, Togashi A, Negishi K, Katayama S. Endogenous carbon monoxide regulates tube formation by human microvascular endothelial cells under high glucose. Circulation. 1997; 96(8):A4067.
  78. Christou H, Magnani B, Morse D, Allred E, Van Marter L, Wessel D, Kourembanas S. Inhaled nitric oxide does not inhibit platelet activation in infants with persistent pulmonary hypertension of the newborn (PPHN). Pediatric Research. 1997; 41:A844.
  79. Wessel D, Adatia I, Thompson J, Kane J, Van Marter L, Stark A, Kourembanas S. Improved oxygenation in a randomized trial of inhaled nitric oxide for PPHN. Pediatric Research. 1996; 39(4):A1498.
  80. Kourembanas S. Regulation of Carbon Monoxide Producation and Vascular Responses. Ketsuatsu - Japanese Journal of Blood Pressure. 1996; 3(2):260-268.
  81. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995 Dec; 96(6):2676-82.
  82. Kostyk SK, Kourembanas S, Wheeler EL, Medeiros D, McQuillan LP, D'Amore PA, Braunhut SJ. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol. 1995 Nov; 269(5 Pt 2):H1583-9.
  83. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res. 1995 Sep; 77(3):638-43.
  84. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1475-9.
  85. Itoh A, Levinson SF, Morita T, Kourembanas S, Brody JS, Mitsialis SA. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors. Cell Mol Biol Res. 1995; 41(3):147-54.
  86. Christou H, Yoshida H, Morita T, Kourembanas S. Increased epithelial cell expression of vascular endothelial growth factor (VEGF) in the lungs of animals with hypoxia-induced pulmonary hypertension. Am. J. Resp. Crit. Care Med. 1995; 151(4):A732.
  87. Kourembanas S, Stark AR. Inhaled NO for PPHN: Basic Biology to Clinical Application (Fanaroff AA and Klaus MH, eds.). 1995 Year Book of Neonatal and Perinatal Medicine. 1995; xvii-xxxvi.
  88. Liu Y, Cox S, Kourembanas S. Hypoxia upregulates the transcription of human vascular endothelial growth factor gene via a 28-bp enhancer. FASEB J. 1995; 9(3):A611.
  89. Morita T, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of endothelial cell gene expression and cGMP content. Circulation. 1995; 92(8):110.
  90. Kourembanas S. Persistent pulmonary hypertension of the newborn: Role of nitric oxide. J. Int. Care Medicine. 1995; 10:270-282.
  91. Morita T, Perrella MA, Lee M-E, Kourembanas S. Hypoxia increases cGMP levels in rat vascular smooth muscle cells via inducation of heme oxygenase-1. 67th Scientific Sessions of the American Heart Assocation, Dallas, TX. 1994.
  92. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol. 1994 Nov; 267(5 Pt 2):H1921-7.
  93. Kourembanas S, Bernfield M. Hypoxia and endothelial-smooth muscle cell interactions in the lung. Am J Respir Cell Mol Biol. 1994 Oct; 11(4):373-4.
  94. Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hsieh CM, Kourembanas S, Lee ME. Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. J Biol Chem. 1994 May 20; 269(20):14595-600.
  95. Kourembanas S, McQuillan L, Christou H, Adatia I, Van Marter L, Kane J, Thompson J, Fackler J, Wessel D, Stark A. Inhaled nitric oxide (NO) alters endogenous endothelin-1 (ET-1) and cGMP levels in newborns with persistent pulmonary hypertension (PPHN). Pediatric Research. 1994; 35(4):234A.
  96. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993 Jul; 92(1):99-104.
  97. Kourembanas S, Leung GK, McQuillan LP. Hypoxia inhibits nitric oxide synthase (NOS) gene expression and nitric oxide (NO) production in endothelial cells. Pediatric Research. 1993; 33:51A.
  98. Yoshizumi M, Kourembanas S, Temizer DH, Cambria RP, Quertermous T, Lee ME. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem. 1992 May 15; 267(14):9467-9.
  99. Kourembanas S. Hypoxic responses of the neonatal endothelium. Semin Perinatol. 1992 Apr; 16(2):140-6.
  100. Kourembanas S, Marsden P, Faller DV. Feedback loops regulated the production of vasoactive agents by human endothelial cells. Pediatric Research. 1992; 31:46A.
  101. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991 Sep; 88(3):1054-7.
  102. Kourembanas S, Marsden P, McQuillan LP, Faller DV. Molecular mechanisms contrbuting to hypoxic vasoconstriction. Pediatric Research. 1991; 29:255A.
  103. Kourembanas S. Shock. Manual of Neonatal Care (Cloherty JP and Stark AR, eds.). 1991; 68-71.
  104. Kourembanas S, Hannan RL, Faller DV. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest. 1990 Aug; 86(2):670-4.
  105. Torday JS, Kourembanas S. Fetal rat lung fibroblasts produce a TGF beta homolog that blocks alveolar type II cell maturation. Dev Biol. 1990 May; 139(1):35-41.
  106. Kourembanas S, Marsden P, Faller DV. Molecular mechanisms contributing to vaso-occlusion in sickle cell disease. Blood. 1990; 76:10S1.
  107. Kourembanas S, Faller DV. Platelet-derived growth factor production by human umbilical vein endothelial cells is regulated by basic fibroblast growth factor. J Biol Chem. 1989 Mar 15; 264(8):4456-9.
  108. Kourembanas S, Hannan RL, Faller DV. Hypoxia stimulates platelet-derived growth factor (PDGF) production by human umbilical vein endothelial cells (HUVEC). Pediatric Research. 1989; 25:54A.
  109. Faller DV, Kourembanas S, Ginsberg D, Hannan R, Collins T, Ewenstein BM, Pober JS, Tantravahi R. Immortalization of human endothelial cells by murine sarcoma viruses, without morphologic transformation. J Cell Physiol. 1988 Jan; 134(1):47-56.
  110. Hannan RL, Kourembanas S, Flanders KC, Rogelj SJ, Roberts AB, Faller DV, Klagsbrun M. Endothelial cells synthesize basic fibroblast growth factor and transforming growth factor beta. Growth Factors. 1988; 1(1):7-17.
  111. Kourembanas S, Faller DV. Regulation of platelet-derived growth factor (PDGF) gene expression by basic fibroblast growth factor (bFGF) in human umbilical vein endothelial cells. Pediatric Research. 1988; 23:245A.
  112. Phelps DS, Church S, Kourembanas S, Taeusch HW, Floros J . Increases in the 35kDa surfactant-associated protein and its mRNA following in vivo dexamethasone treatment of fetal and neonatal rats. Electrophoresis. 1987; 8:235-238.
  113. Floros J, Phelps DS, Kourembanas S, Taeusch HW. Primary translation products, biosynthesis, and tissue specificity of the major surfactant protein in rat. J Biol Chem. 1986 Jan 15; 261(2):828-31.
  114. Kourembanas S, Floros J, Phelps DS, Taeusch HW. Developmental profile of surgactant associated protein (Apoprotein A) in the rat lung. Eleventh Annual New England Conference on Perinatal Resesarch. 1985.
To schedule an appointment: Call 617-919-2355

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close